Tempus AI soars 40% in a week, adding $3.7 billion—over double the Personalis acquisition amount

Tempus AI, Inc. is an American health technology company founded in 2015 by entrepreneur Eric Lefkofsky. Headquartered in Chicago, Tempus was born from Lefkofsky’s personal mission to improve cancer care after his wife’s battle with breast canceren.wikipedia.org. The company’s core focus is on applying AI and data analytics to personalized medicine. Tempus has built what it calls an “operating system” for healthcare: a platform that ingests vast amounts of clinical and molecular data and makes it accessible for treatment decisions and researchinsidermonkey.com. Its goal is to enable doctors and scientists to leverage big data and AI algorithms to tailor treatments to individual patients – improving outcomes in cancer and other diseases.